Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$247.06 - $1507.4 $9.02 Million - $55 Million
-36,500 Reduced 91.25%
3,500 $904,000
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $864,710 - $5.28 Million
3,500 New
3,500 $904,000
Q4 2021

Sep 21, 2023

BUY
$292.08 - $329.01 $10.7 Million - $12 Million
36,500 Added 1042.86%
40,000 $13.2 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $7.97 Million - $8.98 Million
27,300 Added 214.96%
40,000 $13.2 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $1.09 Million - $1.52 Million
9,000 Added 243.24%
12,700 $1.76 Million
Q4 2019

Feb 13, 2020

SELL
$133.47 - $153.48 $120,123 - $138,132
-900 Reduced 19.57%
3,700 $568,000
Q3 2019

Nov 13, 2019

BUY
$135.4 - $146.47 $500,980 - $541,939
3,700 Added 411.11%
4,600 $664,000
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $8.13 Million - $9.36 Million
-65,100 Reduced 98.64%
900 $129,000
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $6.21 Million - $8.41 Million
63,600 Added 2650.0%
66,000 $8.71 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $502,704 - $580,562
-5,300 Reduced 68.83%
2,400 $247,000
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $264,951 - $294,030
2,700 Added 54.0%
7,700 $837,000
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $461,280 - $495,552
4,800 Added 2400.0%
5,000 $493,000
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $433,152 - $487,860
-4,700 Reduced 95.92%
200 $20,000
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $417,774 - $463,638
4,900
4,900 $455,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.